Large-scale testing (Phase 3)Study completedNCT00140582What this trial is testingPrimary Rituximab and MaintenanceWho this might be right forFollicular Lymphoma Lymphoma Study Association 1,217
Testing effectiveness (Phase 2)Looking for participantsNCT07733180What this trial is testingA Study Investigating Alternate Schedules of Tislelizumab Plus Chemotherapy in Japanese Patients With First-line Advanced ESCCWho this might be right forAdvanced Esophageal Squamous Cell CarcinomaMetastatic Esophageal Squamous Cell Carcinoma BeOne Medicines 30
Testing effectiveness (Phase 2)UnknownNCT00425425What this trial is testingCetuximab, Oxaliplatin, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Esophageal CancerWho this might be right forEsophageal Cancer Technical University of Munich 43
Not applicableUnknownNCT03598517What this trial is testingHigh Dose Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT04471818What this trial is testingKetamine or Placebo in Patients With Major Depression and Advanced CancerWho this might be right forMajor Depressive DisorderAdvanced Cancer Instituto Nacional de Cancerologia de Mexico 19
Testing effectiveness (Phase 2)Looking for participantsNCT07154290What this trial is testingInvestigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon Small Cell Lung CancerAdvanced Non Small Cell Lung CancerMetastatic Non Small Cell Lung Cancer+1 more Regeneron Pharmaceuticals 300
Not applicableUnknownNCT05280210What this trial is testingPTC in Personalizing Neoadjuvant Therapy for Patients With Advanced Gastrointestinal TumorWho this might be right forGastrointestinal Neoplasms Peking University 420
Not applicableStudy completedNCT05137782What this trial is testingThe Science of the Art of Palliative CareWho this might be right forGastrointestinal CancerLung CancerAdvanced Cancer Dartmouth-Hitchcock Medical Center 7
Testing effectiveness (Phase 2)WithdrawnNCT00615524What this trial is testingPhase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast CancerWho this might be right forHormone-receptor Positive Breast Cancer GlaxoSmithKline
Early research (Phase 1)Study completedNCT01308723What this trial is testingA Dose-Finding and Exploratory Study of RO5323441 in Combination With Sorafenib in Patients With Hepatocellular CarcinomaWho this might be right forCarcinoma, Hepatocellular Hoffmann-La Roche 6
Testing effectiveness (Phase 2)Ended earlyNCT01326923What this trial is testingInduction Chemo Then Concurrent Chemoradiotherapy With Cetuximab in Locally Advanced Head and Neck Squamous Cell CancerWho this might be right forHead and Neck Squamous Cell Cancer Louisiana State University Health Sciences Center Shreveport 7
Early research (Phase 1)Study completedNCT01872923What this trial is testingDose Escalating Study for Amphinex-based PCI of Bleomycin.Who this might be right forCutaneous or Sub-cutaneous Malignancies PCI Biotech AS 3
Testing effectiveness (Phase 2)WithdrawnNCT01070290What this trial is testingARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy RegimenWho this might be right forGastric Cancer ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Testing effectiveness (Phase 2)UnknownNCT06519110What this trial is testingNeratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 MutationsWho this might be right forAdvanced Solid Tumor Convalife (Shanghai) Co., Ltd. 60
Testing effectiveness (Phase 2)WithdrawnNCT04571710What this trial is testingA Trial of SHR1258 in Patients With Biliary Tract CancerWho this might be right forBiliary Tract Cancer Jiangsu HengRui Medicine Co., Ltd.
Testing effectiveness (Phase 2)Study completedNCT03404960What this trial is testingNiraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based ChemotherapyWho this might be right forPancreatic Adenocarcinoma University of Pennsylvania 104
Testing effectiveness (Phase 2)UnknownNCT00373620What this trial is testingA Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer PatientsWho this might be right forEndometrial Cancer Korean Gynecologic Oncology Group 50
Testing effectiveness (Phase 2)Study completedNCT02087423What this trial is testingA Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer AstraZeneca 446
Early research (Phase 1)Study completedNCT02573259What this trial is testingA Dose Escalation Study Of PF-06801591 In Melanoma, Head And Neck Cancer (SCCHN), Ovarian, Sarcoma, Non-Small Cell Lung Cancer, Urothelial Carcinoma or Other Solid TumorsWho this might be right forPart 1MELANOMASCCHN+6 more Pfizer 147
Large-scale testing (Phase 3)Study completedNCT00216125What this trial is testingCisplatin/Etoposide/Radiotherapy +/- Consolidation Docetaxel in Advanced Stage III Non-Small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer Nasser Hanna, M.D. 243